![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
W Tang, A Ruknudin, WP Yang, SY Shaw, A Knickerbocker and S Kurtz
Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000, USA.
We describe the expression of gpIRK1, an inwardly rectifying K+ channel obtained from guinea pig cardiac cDNA. gpIRK1 is a homologue of the mouse IRK1 channel identified in macrophage cells. Expression of gpIRK1 in Xenopus oocytes produces inwardly rectifying K+ current, similar to the cardiac inward rectifier current IK1. This current is blocked by external Ba2+ and Cs+. Plasmids containing the gpIRK1 coding region under the transcriptional control of constitutive (PGK) or inducible (GAL) promoters were constructed for expression in Saccharomyces cerevisiae. Several observations suggest that gpIRK1 forms functional ion channels when expressed in yeast. gpIRK1 complements a trk1 delta trk2 delta strain, which is defective in potassium uptake. Expression of gpIRK1 in this mutant restores growth on low potassium media. Growth dependent on gpIRK1 is inhibited by external Cs+. The strain expressing gpIRK1 provides a versatile genetic system for studying the assembly and composition of inwardly rectifying K+ channels.
This article has been cited by other articles:
|
|
 |
|
  A. Grishin, H. Li, E. S. Levitan, and E. Zaks-Makhina Identification of {gamma}-Aminobutyric Acid Receptor-interacting Factor 1 (TRAK2) as a Trafficking Factor for the K+ Channel Kir2.1 J. Biol. Chem., October 6, 2006; 281(40): 30104 - 30111. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V.-K. Ton and R. Rao Functional expression of heterologous proteins in yeast: insights into Ca2+ signaling and Ca2+-transporting ATPases Am J Physiol Cell Physiol, September 1, 2004; 287(3): C580 - C589. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Zaks-Makhina, Y. Kim, E. Aizenman, and E. S. Levitan Novel Neuroprotective K+ Channel Inhibitor Identified by High-Throughput Screening in Yeast Mol. Pharmacol., January 1, 2004; 65(1): 214 - 219. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-J. Yao, J. Lemay, N. Rougeau, M. Clement, S. Kurtz, P. Belhumeur, and E. A. Cohen Genetic Selection of Peptide Inhibitors of Human Immunodeficiency Virus Type 1 Vpr J. Biol. Chem., December 6, 2002; 277(50): 48816 - 48826. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Yi, D. L. Minor Jr., Y.-F. Lin, Y. N. Jan, and L. Y. Jan Controlling potassium channel activities: Interplay between the membrane and intracellular factors PNAS, September 25, 2001; 98(20): 11016 - 11023. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Y. Nakamura, M. Artman, B. Rudy, and W. A. Coetzee Inhibition of rat ventricular IK1 with antisense oligonucleotides targeted to Kir2.1 mRNA Am J Physiol Heart Circ Physiol, March 1, 1998; 274(3): H892 - H900. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. D. Klein and T. G. Geary Recombinant Microorganisms as Tools for High Throughput Screening for Nonantibiotic Compounds J Biomol Screen, February 1, 1997; 2(1): 41 - 49. [Abstract] [PDF]
|
|
